Immatics N.V. Ordinary Shares (IMTX) is a publicly traded Healthcare sector company. As of May 21, 2026, IMTX trades at $11.22 with a market cap of $1.45B and a P/E ratio of 0.00. IMTX moved +4.77% today. Year to date, IMTX is +15.08%; over the trailing twelve months it is +107.78%. Its 52-week range spans $3.30 to $12.41. Analyst consensus is strong buy with an average price target of $19.03. Rallies surfaces IMTX's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Hedge funds tracked by Rallies that own IMTX include Orbimed Advisors. The latest tracked quarter is Sep 30, 2025. Rallies shows current holdings, share counts, position changes, and 13F ownership context for Immatics N.V. Ordinary Shares.
| Metric | Value |
|---|---|
| Price | $11.22 |
| Market Cap | $1.45B |
| P/E Ratio | 0.00 |
| EPS | $0.00 |
| Dividend Yield | 0.00% |
| 52-Week High | $12.41 |
| 52-Week Low | $3.30 |
| Volume | 2 |
| Avg Volume | 0 |
| Revenue (TTM) | $0 |
| Net Income | $0 |
| Gross Margin | 0.00% |
8 analysts cover IMTX: 0 strong buy, 8 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $19.03.